FY27 Revenue Target: ₹1,400-1,500 crore
Management indicated existing capacity plus new manufacturing block will enable revenue of ₹1,400-1,500 crore in FY27, with ₹300 crore incremental from new products (7 total) over current base.
PUNJABCHEMICALSANDCROPPR / guidance tracker
Keep management guidance in view.
Punjab Chemicals and · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
EBITDA Margin Improvement to 15%
Targeting improvement from current 12% to 15% EBITDA margin over time through higher contribution from new niche products with better margin profiles than existing basket.
FY26 Capex: ₹40 crore
Total FY26 capex expected at ₹40 crore (₹30 crore done in 9 months + ₹10 crore remaining), with ₹22 crore for asset renewal/compliance and ₹18 crore for capacity expansion/new product lines.
New Block Investment: ₹70 crore
Major new manufacturing block requires approximately ₹70 crore capital expenditure starting from March onward, to be completed for FY27.
Revenue growth of 15-20% in FY27
Management reaffirmed 15-20% YoY revenue growth guidance for FY27, driven by new product ramp-up and steady demand for existing products.
EBITDA margin target of 15% in 2-3 years
Management targets improving EBITDA margin from ~12% to 15% over the next 2-3 years through product mix improvement and cost optimization.
Capex of ₹105-130 Cr in FY27
Planned capex includes ₹25-30 Cr maintenance, ₹20 Cr debottlenecking/compliance, and ₹60-80 Cr for a new production block.
Greenfield site announcement by Q2/Q3 FY27
Management expects to finalize a greenfield land parcel and announce it within Q2 or Q3 of FY27.